Illumina: Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain?
ILMN-NashBio's AGD initiative achieves the milestone of completing 250,000 whole genomes.
Read full article »
Illumina is a California-based biotechnology company that designs and develops products such as sequencing reagents and microarray kits for the life sciences industry.
Read more